Anika Therapeutics, Inc. (ANIK)
16.00
+0.61
(+3.96%)
USD |
NASDAQ |
Apr 17, 16:00
15.99
-0.01
(-0.06%)
After-Hours: 20:00
Anika Therapeutics Shareholders Equity (Quarterly) : 143.46M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| BioCryst Pharmaceuticals, Inc. | -119.15M |
| Masimo Corp. | 721.20M |
| Lantheus Holdings, Inc. | 1.090B |
| Evolus, Inc. | -23.11M |
| TELA Bio, Inc. | 6.313M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 202.44M |
| Total Liabilities (Quarterly) | 58.97M |
| Debt to Equity Ratio | 0.183 |
| Current Ratio | 4.718 |
| Net Debt Paydown Yield | 0.19% |